Company intelligence / Profile preview

DexGen

California, United Statesdexgen.com ↗

Ownership: Private
Development stage: Other

Overview

DexGen is an active, privately held company specializing in the design and manufacture of custom laboratory devices aimed at increasing throughput and optimizing scientific assays. The company supports scientists by providing innovative tools that facilitate advanced research, particularly in drug discovery, high-throughput screening, assay development, robotics, and pharmacology.

Modalities: Device (laboratory devices for assay development and screening)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on DexGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DexGen.

Explore the full profile